Mechanism of enterovirus VP0 maturation cleavage based on the structure of a stabilised assembly intermediate

Natalie J Kingston,Joseph S Snowden,Keith Grehan,Philippa K Hall,Eero V Hietanen,Tim C Passchier,Stephen J Polyak,David J Filman,James M Hogle,David J Rowlands,Nicola J Stonehouse
DOI: https://doi.org/10.1101/2024.04.06.588229
2024-04-06
Abstract:Molecular details of genome packaging are little understood for the majority of viruses. In enteroviruses (EVs), cleavage of the structural protein VP0 into VP4 and VP2 is initiated by the incorporation of RNA into the assembling virion and is essential for infectivity. We have applied a combination of bioinformatic, molecular and structural approaches to generate the first high-resolution structure of an intermediate in the assembly pathway, termed a provirion, which contains RNA and intact VP0. We have demonstrated an essential role of VP0 E096 in VP0 cleavage independent of RNA encapsidation and generated a new model of capsid maturation, supported by bioinformatic analysis. This provides a molecular basis for RNA-dependence, where RNA induces conformational changes required for VP0 maturation, but that RNA packaging itself is not sufficient to induce maturation. These data have implications for understanding production of infectious virions and potential relevance for future vaccine and antiviral drug design.
Microbiology
What problem does this paper attempt to address?
The problem this paper attempts to address is understanding the VP0 maturation cleavage mechanism during the assembly process of enteroviruses (such as enterovirus A71). Specifically, the study focuses on how RNA packaging induces the cleavage of the VP0 protein and further explores the molecular mechanisms involved in this process. By generating a mutant virus (E096A) that can encapsidate RNA but cannot undergo VP0 cleavage, the study stably captures the assembly intermediate state. Through the study of this intermediate structure, the paper reveals the specific details of how RNA packaging triggers VP0 cleavage and proposes a new model for VP0 maturation. This has significant implications for understanding the production of infectious viral particles and for the future design of vaccines and antiviral drugs.